Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
Conditions: HIV; Osteopenia; Osteoporosis; HIV Infections Intervention: Drug: Raltegravir Sponsors: St Vincent's Hospital, Sydney; Merck; Holdsworth House Medical Practice; The Alfred Active, not recruiting - verified July 2010